- EN
Scientific Committee underlines importance of scientific publishing
Boosting the quality and scientific rigour of the EMCDDA’s work is among the aims of the agency’s current three-year work programme (2010–12). Increasing the EMCDDA’s scientific publishing activity and its engagement with the research community are among the activities listed in the programme to attain this objective.
With this in mind, promoting scientific publishing was high on the agenda at the latest EMCDDA Scientific Committee meeting held in Lisbon from 16–17 November. The Committee has taken particular interest in this issue over the last year, as noted in its formal opinion on the three-year work programme. The Committee welcomed the marked increase in the number of articles by EMCDDA staff in scientific peer-reviewed journals in the period 2008–09 and recommended that the agency plan strategically to target journals in future.
In a new formal opinion, the Committee welcomed the 2010 work programme as a positive development and as having the potential to further improve the quality and impact of the EMCDDA’s scientific work. Also scrutinised at the meeting was the quality of the 2009 Annual report, following a review of chapters by four Committee members. Suggestions for improvements included the use of supplementary information sources and consideration of additional analyses (e.g. by groups of countries).
Matthew Hickman, an expert in epidemiology from Bristol University was welcomed as a new member, following the resignation of Jürgen Rehm. Finally, all current members expressed an interest in renewing their mandate at the end of 2010. In December, the Management Board reappointed the members of the Committee for another three-year term (2011–13).
Margareta Nilson
In this issue...
- 2010 priorities and budget
- Management Board: changes at the helm
- EMCDDA and Europol step up information collection on mephedrone
- Guidelines for collecting data on retail drug prices
- Hepatitis C prevalence as a possible indicator of injection-related HIV risk
- Health and prisons in Europe
- Best practice portal: upcoming developments
- European drug prevention quality standards
- Role of Community agencies in EU enlargement process reinforced
- EMCDDA signs accord with Ukrainian Ministry of Health
- New Czech penal code enters into force
- EMCDDA and Canadian partners outline areas for cooperation
- Implementation of the EMCDDA’s five key epidemiological indicators
- Reitox development strategy 2010–15
- Scientific Committee underlines importance of scientific publishing
Drugnet Europe is also available in downloadable PDF format, for printing or offline browsing.
Drugnet Europe is the EMCDDA's newsletter launched in September 1996. The newsletter provides regular and succint information on the Centre's projects and activities to a broad readership.
Page last updated: Friday, 12 March 2010